| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2300044 | 注射用SHR-9839 | SHR-9839 | Lyophilized | Biological Products(1) | New Drug Application | 2023-01-17 | Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
| CXSL2400576 | 注射用SHR-9839 | SHR-9839 | Lyophilized | Biological Products(1) | New Drug Application | 2024-08-29 | Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
| CXSL2400491 | 注射用SHR-9839 | SHR-9839 | Lyophilized | Biological Products(1) | New Drug Application | 2024-07-27 | Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
| CXSL2400126 | 注射用SHR-9839 | SHR-9839 | Lyophilized | Biological Products(1) | New Drug Application | 2024-02-20 | Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
| CXSL2400689 | 注射用SHR-9839 | SHR-9839 | Lyophilized | Biological Products(1) | New Drug Application | 2024-10-12 | Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
| CXSL2400038 | 注射用SHR-9839 | SHR-9839 | Lyophilized | Biological Products(1) | New Drug Application | 2024-01-19 | Shanghai Hengrui Pharmaceutical Co Ltd | view | |||
| CXSL2400687 | 注射用SHR-9839 (sc) | SHR-9839 | Lyophilized | Biological Products(1) | New Drug Application | 2024-10-12 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | view |